Bioethics News

Mitochondrial Manipulation Technology Unlikely in United State Anytime Soon

(Medscape) – Lawmakers in the United Kingdom voted recently to allow fertility clinics to use mitochondrial manipulation technology (MMT) to enable women with mutations in mitochondrial genes to have genetically healthy children . But the US Food and Drug Administration (FDA) is being much more conservative and is awaiting results of further preclinical research before allowing clinical trials to begin. The technology is of concern because it manipulates the germline, something many countries prohibit.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.